These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33160644)

  • 1. Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis.
    Lipworth B; Chan R; Kuo CR
    J Allergy Clin Immunol; 2021 Jan; 147(1):413. PubMed ID: 33160644
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.
    Aschenbrenner DS
    Am J Nurs; 2019 Oct; 119(10):21-22. PubMed ID: 31567245
    [No Abstract]   [Full Text] [Related]  

  • 5. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Boyle JV; Lam K; Han JK
    Immunotherapy; 2020 Feb; 12(2):111-121. PubMed ID: 32075470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
    Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
    Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.
    Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK
    J Allergy Clin Immunol; 2022 Apr; 149(4):1286-1295. PubMed ID: 34543652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
    Bachert C; Zhang L; Gevaert P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A; Liang J
    Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on current evidence for biologics in chronic rhinosinusitis.
    Nasta MS; Chatzinakis VA; Georgalas CC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):18-24. PubMed ID: 31789925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
    Jandus P; Harr T; Soyka MB; Landis BN
    Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
    Bachert C; Gevaert P; Hellings P
    J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab for chronic rhinosinusitis.
    Brañes R; Rosenbaum A; Callejas C; Winter M
    Medwave; 2018 Nov; 18(7):e7347. PubMed ID: 30507897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.